Genmab A-S (GMAB) had the highest return between May 1, 2012 and May 31, 2013 by a large-cap US stock, returning 427.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Genmab A-S (GMAB) | 5/1/2012 - 5/31/2013 | 427.52% |
Insmed (INSM) | 5/1/2012 - 5/31/2013 | 364.36% |
Tesla (TSLA) | 5/1/2012 - 5/31/2013 | 195.07% |
First Solar (FSLR) | 5/1/2012 - 5/31/2013 | 183.74% |
Netflix (NFLX) | 5/1/2012 - 5/31/2013 | 181.79% |
Alnylam Pharmaceuticals (ALNY) | 5/1/2012 - 5/31/2013 | 170.11% |
Ionis Pharmaceuticals (IONS) | 5/1/2012 - 5/31/2013 | 156.69% |
Saia (SAIA) | 5/1/2012 - 5/31/2013 | 153.64% |
Constellation Brands Inc Class A (STZ) | 5/1/2012 - 5/31/2013 | 145.53% |
Tenet Healthcare (THC) | 5/1/2012 - 5/31/2013 | 126.87% |
Generac (GNRC) | 5/1/2012 - 5/31/2013 | 123.32% |
Corpay (CPAY) | 5/1/2012 - 5/31/2013 | 119.29% |
PulteGroup (PHM) | 5/1/2012 - 5/31/2013 | 118.52% |
Apollo Global Management LLC Class A (APO) | 5/1/2012 - 5/31/2013 | 115.05% |
DexCom (DXCM) | 5/1/2012 - 5/31/2013 | 112.99% |
Gilead Sciences (GILD) | 5/1/2012 - 5/31/2013 | 109.74% |
Vertex Pharmaceuticals (VRTX) | 5/1/2012 - 5/31/2013 | 109.19% |
Terawulf (WULF) | 5/1/2012 - 5/31/2013 | 109.03% |
Nomura Holdings Inc ADR (NMR) | 5/1/2012 - 5/31/2013 | 107.81% |
Axon Enterprise (AXON) | 5/1/2012 - 5/31/2013 | 105.86% |
Phillips 66 (PSX) | 5/1/2012 - 5/31/2013 | 101.43% |
Smurfit WestRock (SW) | 5/1/2012 - 5/31/2013 | 100.35% |
Everpure (P) | 5/1/2012 - 5/31/2013 | 99.53% |
Marathon Petroleum (MPC) | 5/1/2012 - 5/31/2013 | 98.77% |
Diamondback Energy (FANG) | 5/1/2012 - 5/31/2013 | 89.51% |
Large-cap stocks are treated as having a market cap of $10B+.